• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: BIOMARKERS IN MS

ECTRIMS 2022 SLIDE DECK

November 10, 2022  

ECTRIMS 2022 HIGHLIGHTS – FRIDAY, OCTOBER 28 EDITION

October 28, 2022  

Three biomarkers of DMT adverse effects proposed

August 25, 2022  

EAN 2022 HIGHLIGHTS – THURSDAY, JUNE 30 EDITION

June 30, 2022  

AAN 2022 HIGHLIGHTS – MONDAY, APRIL 4 EDITION

April 4, 2022  

ECTRIMS 2021 SLIDE DECK

October 22, 2021  

ECTRIMS 2021 HIGHLIGHTS – THURSDAY, OCTOBER 14 EDITION

October 14, 2021  

Highlights from EAN 2021

June 22, 2021  

AAN Daily Reports – Tuesday, April 20 edition

April 20, 2021  

ACTRIMS FORUM 2021 – Highlights

March 2, 2021  
Previous
3
4
5
6
Next

Browse by Topic

  • EPILEPSY (36)
  • MS (412)
  • CLINICAL CASES IN MS (15)
  • BIOMARKERS IN MS (54)
  • AAN 2025 (5)
  • ACTRIMS 2025 (6)
  • Library (17)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • CLINICAL CASES IN MS: A 24 Y.O. WOMAN WITH PARESTHESIAE AND NON-ENHANCING LESIONS posted on April 25, 2025
  • McDonald criteria 2024: what changes can we expect? posted on January 30, 2024
  • Proton pump inhibitors linked to neurological conditions posted on November 29, 2019
Copyright 2025 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions